#BreastCancerResearch Archives

ESMO in 5 Minutes | Professor Man Li: Advances in Early Breast Cancer Treatment

By El Bachir MOURABIT 2024.01.20

Editor's Note: The primary goal for early-stage breast cancer patients is cure, and numerous studies have explored treatment strategies based on this objective. In this edition of the ESMO conference,…

ESMO 2023 | Professor Feng Jin: Less is More – New Evidence Added to Surgery Exemption After Neoadjuvant Therapy for Breast Cancer

By Mourabit Halima 2024.01.18

Editor's Note: The European Society for Medical Oncology (ESMO), as a globally renowned academic conference in the field of oncology, announces numerous cutting-edge developments each year. The ESMO 2023 annual…

ESMO Hot Review | Prof. Ying Fan: DB-04 Study Shows Survival Benefit and Sustained Efficacy of T-DXd Treatment

By Lisa Cui 2024.01.17

Editor's Note: The mid-term analysis results of the DESTINY-Breast04 (DB-04) study were striking, quickly influencing international guidelines such as NCCN and ESMO, and obtaining approvals for indications related to HER2…

ESMO China Voice | Professor Bin Shao : Comprehensive Genomic Analysis of Advanced HR+/HER2- Breast Cancer Patients Using Liquid Biopsy

By Peng Longmei 2024.01.17

Editor's Note: HR+/HER2- is the most common subtype of breast cancer, accounting for approximately 65% to 70% of all breast cancer cases. Improving the survival benefits for patients with advanced…

ESMO 2023丨Professor Feng Jin: CLEVER Study – Repurposing Old Drugs for Targeting Dormant Tumor Cells to Prevent High-Risk Breast Cancer Recurrence

By El Bachir MOURABIT 2024.01.15

Editor's note: Previous studies have indicated a close association between disseminated tumor cells (DTC) in the bone marrow and breast cancer recurrence. At the 2023 ESMO conference, data from the…